Dr. Lerner on OLYMPUS Jelmyto trial: “We've learned a lot of lessons”

In this video, Seth P. Lerner, MD, discusses why the findings of the OLYMPUS trial will change the way that clinicians treat patients with upper tract urothelial carcinoma. Lerner is a professor in the Scott Department of Urology and Beth and Dave Swalm Chair in urologic oncology at the Baylor College of Medicine Medical Center in Houston, Texas.